Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free PARK Stock Alerts

Park Dental Partners (PARK) Competitors

$18.77 -0.98 (-4.96%)
Closing price 07/24/2026 04:00 PM Eastern
Extended Trading
$19.27 +0.50 (+2.66%)
As of 07/24/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

PARK vs. SBC, AIRS, BDSX, LFMD, and BNR

Should you buy Park Dental Partners stock or one of its competitors? MarketBeat compares Park Dental Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Park Dental Partners include SBC Medical Group (SBC), AirSculpt Technologies (AIRS), Biodesix (BDSX), LifeMD (LFMD), and Burning Rock Biotech (BNR). These companies are all part of the "healthcare" industry.

How does Park Dental Partners compare to SBC Medical Group?

Park Dental Partners (NASDAQ:PARK) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Park Dental Partners presently has a consensus target price of $21.75, suggesting a potential upside of 15.88%. SBC Medical Group has a consensus target price of $8.50, suggesting a potential upside of 177.78%. Given SBC Medical Group's higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SBC Medical Group has lower revenue, but higher earnings than Park Dental Partners. SBC Medical Group is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.35-$360K$0.7425.36
SBC Medical Group$169.34M1.85$50.99M$0.397.85

60.8% of SBC Medical Group shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

SBC Medical Group has a net margin of 24.09% compared to Park Dental Partners' net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
SBC Medical Group 24.09%15.90%11.61%

In the previous week, Park Dental Partners had 3 more articles in the media than SBC Medical Group. MarketBeat recorded 5 mentions for Park Dental Partners and 2 mentions for SBC Medical Group. Park Dental Partners' average media sentiment score of 0.63 beat SBC Medical Group's score of 0.44 indicating that Park Dental Partners is being referred to more favorably in the media.

Company Overall Sentiment
Park Dental Partners Positive
SBC Medical Group Neutral

Summary

SBC Medical Group beats Park Dental Partners on 9 of the 16 factors compared between the two stocks.

How does Park Dental Partners compare to AirSculpt Technologies?

AirSculpt Technologies (NASDAQ:AIRS) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Park Dental Partners has a net margin of 0.00% compared to AirSculpt Technologies' net margin of -7.39%. Park Dental Partners' return on equity of 0.00% beat AirSculpt Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
AirSculpt Technologies-7.39% -4.98% -2.36%
Park Dental Partners N/A N/A N/A

91.5% of AirSculpt Technologies shares are owned by institutional investors. 44.6% of AirSculpt Technologies shares are owned by company insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Park Dental Partners had 3 more articles in the media than AirSculpt Technologies. MarketBeat recorded 5 mentions for Park Dental Partners and 2 mentions for AirSculpt Technologies. AirSculpt Technologies' average media sentiment score of 1.87 beat Park Dental Partners' score of 0.63 indicating that AirSculpt Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AirSculpt Technologies
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Park Dental Partners
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Park Dental Partners has higher revenue and earnings than AirSculpt Technologies. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AirSculpt Technologies$151.84M2.14-$11.67M-$0.17N/A
Park Dental Partners$244.49M0.35-$360K$0.7425.36

AirSculpt Technologies presently has a consensus target price of $4.50, indicating a potential downside of 2.39%. Park Dental Partners has a consensus target price of $21.75, indicating a potential upside of 15.88%. Given Park Dental Partners' stronger consensus rating and higher possible upside, analysts plainly believe Park Dental Partners is more favorable than AirSculpt Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AirSculpt Technologies
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

Summary

Park Dental Partners beats AirSculpt Technologies on 11 of the 15 factors compared between the two stocks.

How does Park Dental Partners compare to Biodesix?

Park Dental Partners (NASDAQ:PARK) and Biodesix (NASDAQ:BDSX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

Park Dental Partners has a net margin of 0.00% compared to Biodesix's net margin of -33.26%. Park Dental Partners' return on equity of 0.00% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Biodesix -33.26%-2,101.40%-35.65%

In the previous week, Park Dental Partners and Park Dental Partners both had 5 articles in the media. Biodesix's average media sentiment score of 0.98 beat Park Dental Partners' score of 0.63 indicating that Biodesix is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Park Dental Partners
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Biodesix
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Park Dental Partners has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.35-$360K$0.7425.36
Biodesix$96.10M2.37-$35.26M-$4.06N/A

Park Dental Partners presently has a consensus target price of $21.75, suggesting a potential upside of 15.88%. Biodesix has a consensus target price of $28.33, suggesting a potential upside of 28.79%. Given Biodesix's stronger consensus rating and higher possible upside, analysts clearly believe Biodesix is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
Biodesix
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80

21.0% of Biodesix shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by company insiders. Comparatively, 23.2% of Biodesix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Park Dental Partners beats Biodesix on 8 of the 15 factors compared between the two stocks.

How does Park Dental Partners compare to LifeMD?

LifeMD (NASDAQ:LFMD) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

35.5% of LifeMD shares are owned by institutional investors. 17.2% of LifeMD shares are owned by company insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

LifeMD has higher earnings, but lower revenue than Park Dental Partners. Park Dental Partners is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$193.33M0.93$14.35M$0.0574.20
Park Dental Partners$244.49M0.35-$360K$0.7425.36

LifeMD presently has a consensus price target of $9.14, suggesting a potential upside of 146.44%. Park Dental Partners has a consensus price target of $21.75, suggesting a potential upside of 15.88%. Given LifeMD's higher possible upside, equities analysts plainly believe LifeMD is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
2 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.60
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

LifeMD has a net margin of 2.37% compared to Park Dental Partners' net margin of 0.00%. Park Dental Partners' return on equity of 0.00% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD2.37% -150.88% -22.59%
Park Dental Partners N/A N/A N/A

In the previous week, Park Dental Partners had 1 more articles in the media than LifeMD. MarketBeat recorded 5 mentions for Park Dental Partners and 4 mentions for LifeMD. Park Dental Partners' average media sentiment score of 0.63 beat LifeMD's score of 0.51 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeMD
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Park Dental Partners
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

LifeMD and Park Dental Partners tied by winning 8 of the 16 factors compared between the two stocks.

How does Park Dental Partners compare to Burning Rock Biotech?

Burning Rock Biotech (NASDAQ:BNR) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.

30.0% of Burning Rock Biotech shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Park Dental Partners has a consensus target price of $21.75, suggesting a potential upside of 15.88%. Given Park Dental Partners' stronger consensus rating and higher probable upside, analysts clearly believe Park Dental Partners is more favorable than Burning Rock Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Burning Rock Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

Park Dental Partners has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock Biotech$514.43M0.18-$7.92M-$0.82N/A
Park Dental Partners$244.49M0.35-$360K$0.7425.36

Park Dental Partners has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -11.57%. Park Dental Partners' return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock Biotech-11.57% -10.98% -7.33%
Park Dental Partners N/A N/A N/A

In the previous week, Park Dental Partners had 3 more articles in the media than Burning Rock Biotech. MarketBeat recorded 5 mentions for Park Dental Partners and 2 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 1.68 beat Park Dental Partners' score of 0.63 indicating that Burning Rock Biotech is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Burning Rock Biotech
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Park Dental Partners
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Park Dental Partners beats Burning Rock Biotech on 11 of the 15 factors compared between the two stocks.

Get Park Dental Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PARK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PARK vs. The Competition

Export
MetricPark Dental PartnersServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$89.17M$2.00B$17.17B$12.26B
Dividend YieldN/AN/A5.20%9.79%
P/E Ratio25.3625.8519.2723.64
Price / Sales0.356.1135.0889.27
Price / Cash4.502,072.91353.9459.64
Price / Book3.5230.8111.876.07
Net Income-$360K-$30.36M-$15.57M$331.99M
7 Day Performance-3.55%20.95%-1.33%-0.63%
1 Month Performance2.85%23.99%-0.36%-2.00%
1 Year PerformanceN/AN/A-27.59%13.62%

Park Dental Partners Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PARK
Park Dental Partners
3.7492 of 5 stars		$18.77
-5.0%		$21.75
+15.9%		N/A$89.17M$244.49M25.361,212
SBC
SBC Medical Group
3.243 of 5 stars		$3.10
+0.0%		$8.50
+174.1%		-37.2%$318.51M$173.61M7.96N/A
AIRS
AirSculpt Technologies
0.7757 of 5 stars		$4.24
+0.8%		$4.50
+6.3%		-26.7%$298.78M$151.82MN/A240
BDSX
Biodesix
3.689 of 5 stars		$21.54
+0.5%		$28.33
+31.6%		+163.3%$223.91M$88.50MN/A220
LFMD
LifeMD
2.8611 of 5 stars		$4.53
-4.8%		$9.14
+101.8%		-65.2%$219.02M$194.05M90.60230

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PARK) was last updated on 7/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel